Literature DB >> 24291334

Cell experimental studies on sonoporation: state of the art and remaining problems.

Hao Yu1, Liang Xu2.   

Abstract

Sonoporation is the formation of transient pores on cell membrane by ultrasound exposure. Sonoporation can be applied to the increasing delivery of drug or gene into cells. However, there are some problems encountered in sonoporation studies. The mechanisms to produce sonoporation are very complicated; there are too many experimental parameters affecting the sonoporation results; and there are many bio-effects accompanied with sonoporation. In the article, the cell experimental studies on sonoporation were sorted, including experimental methods, mechanisms to produce sonoporation, correlations between sonoporation experimental parameters and results, and bioeffects accompanied with sonoporation. We'd like to make the concepts about sonoporation clearer. The sonoporation technology may be a promising auxiliary technology to promote drug or gene therapy in the future.
Copyright © 2013 Elsevier B.V. All rights reserved.

Keywords:  Cell experiment; Delivery of drug or gene; Microbubble; Sonoporation; Ultrasound

Mesh:

Year:  2013        PMID: 24291334     DOI: 10.1016/j.jconrel.2013.11.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

Review 1.  Cell mechanics in biomedical cavitation.

Authors:  Qianxi Wang; Kawa Manmi; Kuo-Kang Liu
Journal:  Interface Focus       Date:  2015-10-06       Impact factor: 3.906

2.  Membrane blebbing as a recovery manoeuvre in site-specific sonoporation mediated by targeted microbubbles.

Authors:  Ruen Shan Leow; Jennifer M F Wan; Alfred C H Yu
Journal:  J R Soc Interface       Date:  2015-04-06       Impact factor: 4.118

3.  Multicore Liquid Perfluorocarbon-Loaded Multimodal Nanoparticles for Stable Ultrasound and 19F MRI Applied to In Vivo Cell Tracking.

Authors:  Olga Koshkina; Guillaume Lajoinie; Francesca Baldelli Bombelli; Edyta Swider; Luis J Cruz; Paul B White; Ralf Schweins; Yusuf Dolen; Eric A W van Dinther; N Koen van Riessen; Sarah E Rogers; Remco Fokkink; Ilja K Voets; Ernst R H van Eck; Arend Heerschap; Michel Versluis; Chris L de Korte; Carl G Figdor; I Jolanda M de Vries; Mangala Srinivas
Journal:  Adv Funct Mater       Date:  2019-03-13       Impact factor: 18.808

4.  Localization of nanospheres in pheochromocytoma-like cells following exposure to high-frequency electromagnetic fields at 18 GHz.

Authors:  Palalle G Tharushi Perera; Denver P Linklater; Erim Kosyer; Rodney Croft; Elena P Ivanova
Journal:  R Soc Open Sci       Date:  2022-06-29       Impact factor: 3.653

Review 5.  Ultrasound-enhanced transdermal delivery: recent advances and future challenges.

Authors:  Matthias A Oberli; Carl M Schoellhammer; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2014-07

6.  In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.

Authors:  Fernando Mérida; Carlos Rinaldi; Eduardo J Juan; Madeline Torres-Lugo
Journal:  Int J Nanomedicine       Date:  2020-01-21

Review 7.  New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction.

Authors:  Yang-Ying Liao; Zhi-Yi Chen; Yi-Xiang Wang; Yan Lin; Feng Yang; Qiu-Lan Zhou
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

8.  An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro.

Authors:  Samantha M Fix; Anthony Novell; Yeoheung Yun; Paul A Dayton; Christopher B Arena
Journal:  J Ther Ultrasound       Date:  2017-01-24

9.  Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters.

Authors:  Maochen Wang; Yi Zhang; Chenliang Cai; Juan Tu; Xiasheng Guo; Dong Zhang
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

10.  UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.

Authors:  Lizhou Lin; Yu Fan; Feng Gao; Lifang Jin; Dan Li; Wenjie Sun; Fan Li; Peng Qin; Qiusheng Shi; Xiangyang Shi; Lianfang Du
Journal:  Theranostics       Date:  2018-02-14       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.